ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $601,000 | +13.6% | 4,700 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $529,000 | -73.5% | 4,700 | -77.6% | 0.01% | -75.0% |
| Q2 2020 | $1,995,000 | +6.0% | 20,940 | 0.0% | 0.03% | -6.7% |
| Q1 2020 | $1,882,000 | +1047.6% | 20,940 | +575.5% | 0.03% | +1400.0% |
| Q4 2019 | $164,000 | -24.8% | 3,100 | -43.6% | 0.00% | 0.0% |
| Q3 2019 | $218,000 | -3.5% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $226,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |